INVO Fertility, Inc.
IVF
$1.46
-$0.03-2.01%
NASDAQ
03/31/2025 | |||||
---|---|---|---|---|---|
Revenue | -74.94% | ||||
Total Other Revenue | -- | ||||
Total Revenue | -74.94% | ||||
Cost of Revenue | -71.43% | ||||
Gross Profit | -79.39% | ||||
SG&A Expenses | -58.14% | ||||
Depreciation & Amortization | -74.50% | ||||
Other Operating Expenses | -- | ||||
Total Operating Expenses | -62.71% | ||||
Operating Income | 44.81% | ||||
Income Before Tax | -648.06% | ||||
Income Tax Expenses | -- | ||||
Earnings from Continuing Operations | -644.12% | ||||
Earnings from Discontinued Operations | -- | ||||
Extraordinary Item & Accounting Change | -- | ||||
Minority Interest in Earnings | -- | ||||
Net Income | -644.12% | ||||
EBIT | 44.81% | ||||
EBITDA | 47.35% | ||||
EPS Basic | -270.43% | ||||
Normalized Basic EPS | 19.70% | ||||
EPS Diluted | -270.45% | ||||
Normalized Diluted EPS | 19.70% | ||||
Average Basic Shares Outstanding | 246.41% | ||||
Average Diluted Shares Outstanding | 246.41% | ||||
Dividend Per Share | -- | ||||
Payout Ratio | -- |